Pain Coping Skills Training Beneficial During Maintenance Hemodialysis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- Pain coping skills training (PSCT) is beneficial for patients undergoing maintenance hemodialysis and experiencing chronic pain, according to a study published online Dec. 30 in JAMA Internal Medicine.
Laura M. Dember, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the effectiveness of a cognitive behavioral intervention, PSCT, on pain interference in a multicenter randomized clinical trial. Adults undergoing maintenance hemodialysis and experiencing chronic pain were randomly assigned to PSCT or usual care (319 and 324 participants, respectively).
The researchers found that the PSCT group had a larger reduction in the Brief Pain Inventory (BPI) Interference score than the usual care group at week 12 (between-group difference, −0.49). At 24 weeks, the effect persisted (between-group difference in BPI Interference score, −0.48), but the effect was attenuated at week 36 (between-group difference, −0.34). A decrease in BPI Interference score of more than 1 point (minimal clinically important difference) occurred in 50.9 and 36.6 percent of patients in the PSCT and usual care groups, respectively, at 12 weeks and in 55.0 versus 42.8 percent, respectively, at 24 weeks (odds ratios, 1.79 and 1.59, respectively). For secondary outcomes, favorable changes were also seen for PSCT.
"While the effect on the overall cohort was of modest magnitude, the intervention resulted in a clinically meaningful improvement in pain interference for a substantial proportion of participants," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-31 12:00
Read more
- Experts Warn of Growing Risks as Bird Flu Cases Rise
- Breast Cancer Risk Increased With Weight Gain After Age 35 Years
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
- FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce Bleeding Episodes in People with Hemophilia A or B with Inhibitors
- FDA Expands Approval of Vtama to Include Atopic Dermatitis
- 1 in 3 Older Americans Say They Feel Lonely, Poll Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions